Affinage · Plasmodium

PHB1

PF3D7_0829200 · prohibitin 1

Annotated
2026-09-08
5 papers in source corpus 4 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PHB1 (PF3D7_0829200) is an essential mitochondrial protein of Plasmodium that localizes to the branched mitochondrial network of P. falciparum asexual and sexual blood stages (PMID:37088154). Within the parasite mitochondrion it physically associates with PfPHB2, forming heterodimeric prohibitin complexes analogous to canonical inner-membrane PHB1–PHB2 assemblies (PMID:37088154, PMID:32883936). Its mitochondrial function is conserved: PHB1 rescues S. cerevisiae PHB1-deletion mutants, restoring mitochondrial DNA stability, mitochondrial integrity, and cell growth (PMID:37088154). In P. berghei the ortholog is refractory to genomic deletion, indicating that prohibitin function is required for blood-stage survival (PMID:29669282). PHB1 is the molecular target of the PHB inhibitor Rocaglamide, which suppresses growth of yeast strains complemented with PHB1 and inhibits P. falciparum asexual, gametocyte, and oocyst stages at nanomolar concentrations, marking PHB1 as a druggable antimalarial target (PMID:37088154). Beyond these observations, the precise biochemical role of PHB1 in maintaining the mitochondrial inner membrane has not been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2018 Medium

    Establishing whether the Plasmodium prohibitin 1 ortholog is essential addressed whether it could serve as a viable drug target rather than a dispensable mitochondrial passenger.

    Evidence Fluorescence microscopy and attempted (unsuccessful) gene deletion in P. berghei

    PMID:29669282

    Open questions at the time
    • Essentiality shown in P. berghei, not directly in P. falciparum PHB1
    • Failed deletion does not reveal which mitochondrial function is required
    • No conditional knockdown to define the essential process
  2. 2020 Low

    Testing whether PHB1 partners with PHB2 addressed whether the parasite builds heterodimeric prohibitin complexes like canonical eukaryotes.

    Evidence Yeast two-hybrid analysis with homology modelling

    PMID:32883936

    Open questions at the time
    • Single method (yeast two-hybrid) with no in-parasite biochemical validation in this study
    • Supercomplex stoichiometry inferred from homology, not measured
    • No structure of the parasite complex
  3. 2023 Medium

    Determining PHB1's subcellular location and its physical interaction with PfPHB2 in parasites confirmed it is a bona fide mitochondrial prohibitin acting in a complex, not an isolated protein.

    Evidence Immunostaining, subcellular fractionation, and co-immunoprecipitation in P. falciparum 3D7

    PMID:32883936 PMID:37088154

    Open questions at the time
    • Co-IP does not resolve direct versus indirect contact or complex architecture
    • Other complex members not identified
    • Interaction not mapped to specific domains
  4. 2023 Medium

    Heterologous complementation established that PHB1 carries out a conserved mitochondrial function, defining its cellular role in mtDNA stability and organellar integrity.

    Evidence Functional complementation of S. cerevisiae PHB1-deletion mutants with multiple phenotypic readouts

    PMID:37088154

    Open questions at the time
    • Function inferred from yeast rescue, not directly demonstrated in the parasite
    • Biochemical mechanism of mtDNA stabilization unresolved
    • Native substrates or client proteins unidentified
  5. 2023 Medium

    Identifying PHB1 as the molecular target of Rocaglamide connected the mitochondrial protein to a chemically tractable, transmission-blocking antimalarial strategy.

    Evidence Rocaglamide inhibition of PHB1-complemented yeast plus P. falciparum growth assays across asexual, gametocyte, and oocyst stages

    PMID:37088154

    Open questions at the time
    • Direct binding of Rocaglamide to parasite PHB1 not demonstrated biochemically
    • Whether Roc-A engages the PHB1–PHB2 complex or PHB1 alone unclear
    • Resistance mechanisms and target selectivity not defined
  6. 2026 Low

    Placing PHB1 among the four mitochondrial SPFH proteins situated it within a broader membrane-scaffold family sharing the organelle.

    Evidence Epitope tagging and fluorescence microscopy in a comparative SPFH family study

    PMID:41662436

    Open questions at the time
    • PHB1-specific functional data not provided beyond mitochondrial localization
    • Functional relationship among the SPFH proteins not established for PHB1
    • Study focus was on a different SPFH member

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct in-parasite biochemical function of PHB1 — its native complex architecture, molecular substrates, and mechanism of maintaining mitochondrial DNA and membrane integrity — remains undefined.
  • No structural model of the parasite PHB1–PHB2 complex
  • No direct demonstration of mtDNA/integrity function in the parasite itself
  • Direct Rocaglamide–PHB1 binding not shown

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
Complex memberships
PHB1–PHB2 heterodimeric prohibitin complex

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2023 PfPHB1 (PF3D7_0829200) localizes to the mitochondrion of P. falciparum asexual and sexual blood stages, as demonstrated by immunostaining showing branched mitochondrial structures, and was further validated as a mitochondrial organellar protein by fractionation/localization studies. Immunostaining, subcellular fractionation/localization validation Biochemical pharmacology Medium 37088154
2023 PfPHB1 (PF3D7_0829200) physically interacts with PfPHB2 within P. falciparum mitochondria, as demonstrated by co-immunoprecipitation/interaction studies. Co-immunoprecipitation / protein interaction assay in parasite Biochemical pharmacology Medium 32883936 37088154
2020 PfPHB1 (PF3D7_0829200) interacts with PfPHB2 as shown by yeast two-hybrid analysis, suggesting they form heterodimeric supercomplexes analogous to canonical PHB1-PHB2 complexes in the mitochondrial inner membrane. Yeast two-hybrid analysis; homology modelling Indian journal of medical microbiology Low 32883936
2023 PfPHB1 (PF3D7_0829200) functionally complements yeast PHB1 mutants in S. cerevisiae, where it stabilizes mitochondrial DNA, maintains mitochondrial integrity, and rescues cell growth, demonstrating conserved mitochondrial function. Heterologous functional complementation in Saccharomyces cerevisiae PHB1 deletion mutants Biochemical pharmacology Medium 37088154
2023 Rocaglamide (Roc-A), a known PHB inhibitor, inhibits growth of yeast cells complemented with PfPHB1 (PF3D7_0829200), validating PfPHB1 as a molecular target of Roc-A and contributing to Roc-A's nanomolar-range inhibition of P. falciparum asexual and sexual (gametocyte, oocyst) stages. Pharmacological inhibition of yeast complementation strains expressing PfPHB1; P. falciparum growth assay with Roc-A Biochemical pharmacology Medium 37088154
2018 Prohibitin 1 (the conserved PHB1 ortholog) localizes to the P. berghei mitochondrion (along with prohibitin 2 and stomatin-like protein), and could not be deleted from the Plasmodium genome, indicating it is essential for blood-stage parasite survival. Fluorescence microscopy (mitochondrial localization); attempted gene deletion (unsuccessful) Cell reports Medium 29669282
2026 PHB1 (PF3D7_0829200) is one of four SPFH proteins in P. falciparum that all localize to the parasite mitochondrion, as confirmed by epitope-tagging and localization studies in this comparative study of SPFH family members. Epitope tagging and fluorescence microscopy (comparative SPFH localization study) PLoS pathogens Low 41662436

Source papers

Stage 0 corpus · 5 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2018 An Unusual Prohibitin Regulates Malaria Parasite Mitochondrial Membrane Potential. Cell reports 28 29669282
2023 Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite. Biochemical pharmacology 9 37088154
2020 Functional studies of Plasmodium falciparum's prohibitin1 and prohibitin 2 in yeast. Indian journal of medical microbiology 7 32883936
2025 Development of a multi-epitope vaccine candidate targeting blood-stage of malaria through immunoinformatics approach. Human immunology 3 40669099
2026 Plasmodium falciparum stomatin-like protein forms a putative complex with a metalloprotease in distinct mitochondrial loci. PLoS pathogens 1 41662436